We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Evolutec Grp | LSE:EVC | London | Ordinary Share | GB00B01JLR99 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 41.00 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
TIDMNANO
RNS Number : 2756C
Nanoco Group PLC
14 October 2015
For immediate release 14 October 2015
NANOCO GROUP PLC
("Nanoco" or the "Company")
Director Share Purchase
Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, was notified on 14 October 2015 that David Blain, the Company's Chief Financial Officer, had purchased 14,700 ordinary shares of 10p each in the Company ("Ordinary Shares") on 14 October 2015 at an average price of 57.97p per Ordinary Share.
The Ordinary Shares are held by Blain Associates Limited, a company of which David Blain is the sole shareholder.
Following this transaction, David Blain has a beneficial interest in 14,700 Ordinary Shares, representing approximately 0.006% of the Company's issued share capital.
For further information, please contact:
Nanoco Tel: +44 (0) 161 603 7900 Michael Edelman, Chief Executive Officer David Blain, Chief Financial Officer Canaccord Genuity - Joint Tel: +44 (0) 20 7523 8000 Broker Simon Bridges Cameron Duncan Mark Whitmore Liberum - Joint Broker Tel: +44 (0) 20 3100 2000 Neil Patel Richard Bootle Steven Tredget Buchanan Tel: +44 (0) 20 7466 5000 Mark Court / Sophie Cowles / Stephanie Watson
Notes for editors:
About Nanoco Group plc
Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nano-materials for use in multiple applications including LCD displays, lighting, solar cells and bio-imaging. In the display market, it has an exclusive manufacturing and marketing licensing agreement with The Dow Chemical Company.
Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development executives in Japan, Korea and Taiwan. Its technology is protected worldwide by a large and growing patent estate.
Nanoco is listed on the main market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSEADELFDLSFFF
(END) Dow Jones Newswires
October 14, 2015 09:45 ET (13:45 GMT)
1 Year Evolutec Chart |
1 Month Evolutec Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
